EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment

J Ma, E S Björnsson, N Chalasani

Seminars in Liver Disease · 01.05.2024 · 44 (02) · 239-257

DOI: 10.1055/s-0044-1787062 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.05.2024. Verfasst von J Ma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Anti-Bacterial Agents, Antifungal Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 190 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiosyncratic drug-induced liver injury (DILI) is a rare and unpredictable form of hepatotoxicity. While its clinical course is usually benign, cases leading to liver transplantation or death can occur. Based on modern prospective registries, antimicrobials including antibiotics and antifungals are frequently implicated as common causes. Amoxicillin–clavulanate ranks as the most common cause for DILI in the Western World. Although the absolute risk of hepatotoxicity of these agents is low, as their usage is quite high, it is not uncommon for practitioners to encounter liver injury following the initiation of antibiotic or antifungal therapy. In this review article, mechanisms of hepatoxicity are presented. The adverse hepatic effects of well-established antibiotic and antifungal agents are described, including their frequency, severity, and pattern of injury and their HLA risks. We also review the drug labeling and prescription guidance from regulatory bodies, with a focus on individuals with hepatic impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver InjuryAnti-Bacterial AgentsAntifungal AgentsHumansRisk FactorsDrug LabelingLiver

Substanzen

Anti-Bacterial AgentsAntifungal Agents

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Department of Gastroenterology, Landspitali University Hospital Reykjavik, Reykjavik, Iceland.
  • Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Zitieren

APA

Ma, J., Björnsson, E. S., & Chalasani, N. (2024). Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment. Seminars in Liver Disease, 44(02), 239-257. https://doi.org/10.1055/s-0044-1787062

Vancouver

Ma J, Björnsson ES, Chalasani N. Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment. Seminars in Liver Disease. 2024;44(02):239-257. doi:10.1055/s-0044-1787062

BibTeX
@article{Ma2024,
  author = {Ma, J and Björnsson, E S and Chalasani, N},
  title = {Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment},
  journal = {Seminars in Liver Disease},
  year = {2024},
  volume = {44},
  number = {02},
  pages = {239--257},
  doi = {10.1055/s-0044-1787062}
}
Kostenlos starten →